Skip to main content
Premium Trial:

Request an Annual Quote

William Welch

Trovagene has appointed William Welch as CEO, effective immediately, and has also annouced that Matthew Posard, the Company's Chief Commercial Officer, has left the firm.

Welch served previously as president and CEO of Sequenom where he initially began his career as senior vice president. Prior to joining Sequenom, Welch was a consultant to various molecular diagnostic companies in the personalized medicine sector. Before that, he held leadership and management roles at Monogram Biosciences, La Jolla Pharmaceuticals, Dade Behring MicroScan, and Abbott Laboratories.